At a glance
ClinicalIndex Comparison RecordN/ACompleted· 90 enrolled
Drug / intervention
FoTvdietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multicenter Double-Blind, Placebo-Controlled RCT of Fomitopsis Officinalis/Trametes Versicolor for COVID-19
In Brief
A clinical study evaluating FoTv for COVID-19 Vaccination. Completed, enrolled 90 participants across 1 site.
Detailed Summary
This is a randomized, double-blind, placebo-controlled clinical trial to evaluate the effect of two polypore mushrooms, Fomitopsis officinalis and Trametes versicolor (FoTv), for use as an adjunct to vaccination for COVID-19 in a general population at the time of COVID-19 vaccination.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCOVID-19 Vaccination
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartJun 2021
First PostedJul 2021
Primary CompletionJan 2022
Study CompletionJul 2022
TodayJul 2026
First PostedJul 6, 2021
Enrollment StartJun 10, 2021
Primary CompletionJan 21, 2022
Study CompletionJul 6, 2022
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 5.0 years ago
Interventions
FoTvdietary
Fomitopsis Officinalis and Trametes Versicolor